ÈÕ±¾avÉ«ÇéƬ

Dr. Christine M. Salvatore is Chief of Pediatric Infectious Diseases in the Department of Pediatrics. She is an Associate Professor of Clinical Pediatrics at ÈÕ±¾avÉ«ÇéƬ and an Associate Attending Pediatrician at NewYork-Presbyterian/ÈÕ±¾avÉ«ÇéƬ Medical Center. She is board certified in both Pediatrics and Pediatric Infectious Diseases.She received her M.D. in Italy at the University of Trieste, Faculty of Medicine and Surgery, and completed her pediatric residency in Italy at Burlo Garofolo Children`s Hospital in Trieste (Italy). After working in Italy as an attending pediatrician, Dr. Salvatore came to the United States where she completed additional pediatric training at Jacobi Medical Center in New York City, and a fellowship in pediatric infectious disease at the University of Texas Southwestern Medical Center at Dallas.   Her interest in pediatric infectious diseases began in Italy, where she collaborated as Principal Site Investigator with the PENTA (Pediatric European Network for the Treatment of AIDS) and the Italian Register for HIV Infection in Children. Since then, Dr. Salvatore has been involved in several clinical trials.   Clinical and translational research is one of her main interests. While at UT Southwestern Medical Center at Dallas, she also conducted basic research studying, in a murine model, treatment strategies for Mycoplasma pneumoniae infections and the pathogenesis of Mycoplasma pneumoniae respiratory infections. Since at ÈÕ±¾avÉ«ÇéƬ she has conducted bench to bedside translational research trying to establish the effectiveness of fungal biomarkers, in particular (1->3)-ß-D-glucan, in the diagnosis and therapeutic monitoring of invasive fungal infections in pediatrics. Studying the epidemiology, diagnosis and treatment of joint and bone infections in children is another of her interests.    Demonstrating her longstanding commitment to medical education, she has given lectures to medical students, residents and medical staff on general pediatrics, pediatric infectious diseases, pediatric HIV, infectious complications in pediatric immunocompromised hosts and antimicrobials principles.